- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2022-03-04
2027-03-30
2030-03-30
1300
NCT05714111
IRCCS San Raffaele
IRCCS San Raffaele
OBSERVATIONAL
Radiology Registry on Pancreatic Malignancies
The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.
Single center, observational (retrospective and prospective) will collect all available parameters to assess the clinical outcome of the patients (progression free survival (PFS), overall survival (OS), local progression free survival LTPFS), response to treatment) with pancreatic neoplasms presenting to San Raffaele. Patient assignment to a given diagnostic and/or therapeutic procedure is not related to random assignment methods but is part of the ordinary therapeutic strategy planned for each patient on an individual basis and after multidisciplinary discussion.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2023-01-25 | N/A | 2024-04-11 |
2023-02-03 | N/A | 2024-04-12 |
2023-02-06 | N/A | 2024-04 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Progression- free survival | Time from start of observation to disease progression | From date of intervention until the date of first documented progression, up to a maximum of 3 years |
| Local progression free survival | Time between (start of) a locoregional treatment and local disease progression | From date of intervention until the date of first documented local progression assessed up to a maximum of 3 years |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Overall Survival | The length of time from either the date of diagnosis or the start of treatment for a disease, in which the patients are still alive | From date of treatment until the date of death from any cause assessed up to 3 years |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
